A citation-based method for searching scientific literature

Robert E Ratner. Diabetes Technol Ther 2018
Times Cited: 11







List of co-cited articles
8 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity




Effect of Continuous Glucose Monitoring on Glycemic Control in Adults With Type 1 Diabetes Using Insulin Injections: The DIAMOND Randomized Clinical Trial.
Roy W Beck, Tonya Riddlesworth, Katrina Ruedy, Andrew Ahmann, Richard Bergenstal, Stacie Haller, Craig Kollman, Davida Kruger, Janet B McGill, William Polonsky,[...]. JAMA 2017
333
18

Hyperglycemic crises in adult patients with diabetes.
Abbas E Kitabchi, Guillermo E Umpierrez, John M Miles, Joseph N Fisher. Diabetes Care 2009
647
18


Hypoglycemia in diabetes.
Philip E Cryer, Stephen N Davis, Harry Shamoon. Diabetes Care 2003
659
18



Effect of Insulin Degludec vs Insulin Glargine U100 on Hypoglycemia in Patients With Type 1 Diabetes: The SWITCH 1 Randomized Clinical Trial.
Wendy Lane, Timothy S Bailey, Gregg Gerety, Janusz Gumprecht, Athena Philis-Tsimikas, Charlotte Thim Hansen, Thor S S Nielsen, Mark Warren. JAMA 2017
95
9

Possible Ways to Improve Postprandial Glucose Control in Type 1 Diabetes.
Halis Kaan Akturk, Amanda Rewers, Hal Joseph, Nicole Schneider, Satish K Garg. Diabetes Technol Ther 2018
10
10

Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030.
Christian Bommer, Vera Sagalova, Esther Heesemann, Jennifer Manne-Goehler, Rifat Atun, Till Bärnighausen, Justine Davies, Sebastian Vollmer. Diabetes Care 2018
181
9

Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German/Austrian DPV registries.
Ruth S Weinstock, Ingrid Schütz-Fuhrmann, Crystal G Connor, Julia M Hermann, David M Maahs, Morten Schütt, Shivani Agarwal, Sabine E Hofer, Roy W Beck, Reinhard W Holl. Diabetes Res Clin Pract 2016
22
9

Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth.
Giuseppina Imperatore, James P Boyle, Theodore J Thompson, Doug Case, Dana Dabelea, Richard F Hamman, Jean M Lawrence, Angela D Liese, Lenna L Liu, Elizabeth J Mayer-Davis,[...]. Diabetes Care 2012
259
9


Why don't diabetes patients achieve recommended risk factor targets? Poor adherence versus lack of treatment intensification.
Julie A Schmittdiel, Connie S Uratsu, Andrew J Karter, Michele Heisler, Usha Subramanian, Carol M Mangione, Joe V Selby. J Gen Intern Med 2008
154
9


Reduced hypoglycemia risk with insulin glargine: a meta-analysis comparing insulin glargine with human NPH insulin in type 2 diabetes.
Julio Rosenstock, George Dailey, Massimo Massi-Benedetti, Andreas Fritsche, Zhengning Lin, Alan Salzman. Diabetes Care 2005
227
9

The Hybrid Closed-Loop System: Evolution and Practical Applications.
Kathryn W Weaver, Irl B Hirsch. Diabetes Technol Ther 2018
23
9

Hypoglycaemia with insulin aspart: a double-blind, randomised, crossover trial in subjects with Type 1 diabetes.
S R Heller, S Colagiuri, S Vaaler, B H R Wolffenbuttel, K Koelendorf, H H Friberg, K Windfeld, A Lindholm. Diabet Med 2004
65
9

The epidemic of type 1 diabetes: what is it telling us?
Gregory P Forlenza, Marian Rewers. Curr Opin Endocrinol Diabetes Obes 2011
71
9

Trends in Drug Utilization, Glycemic Control, and Rates of Severe Hypoglycemia, 2006-2013.
Kasia J Lipska, Xiaoxi Yao, Jeph Herrin, Rozalina G McCoy, Joseph S Ross, Michael A Steinman, Silvio E Inzucchi, Thomas M Gill, Harlan M Krumholz, Nilay D Shah. Diabetes Care 2017
131
9


Insulin prices, availability and affordability: a cross-sectional survey of pharmacies in Hubei Province, China.
Chenxi Liu, Xinping Zhang, Chaojie Liu, Margaret Ewen, Zinan Zhang, Guoqin Liu. BMC Health Serv Res 2017
14
9

Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial.
Chantal Mathieu, Bruce W Bode, Edward Franek, Athena Philis-Tsimikas, Ludger Rose, Tina Graungaard, Anne Birk Østerskov, David Russell-Jones. Diabetes Obes Metab 2018
36
9


Consensus Statement by the American Association of Clinical Endocrinologists/American College of Endocrinology insulin pump management task force.
George Grunberger, Jill M Abelseth, Timothy S Bailey, Bruce W Bode, Yehuda Handelsman, Richard Hellman, Lois Jovanovič, Wendy S Lane, Philip Raskin, William V Tamborlane,[...]. Endocr Pract 2014
75
9



Combined SGLT1 and SGLT2 Inhibitors and Their Role in Diabetes Care.
Thomas Danne, Torben Biester, Olga Kordonouri. Diabetes Technol Ther 2018
16
9

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes.
Satish K Garg, Stuart A Weinzimer, William V Tamborlane, Bruce A Buckingham, Bruce W Bode, Timothy S Bailey, Ronald L Brazg, Jacob Ilany, Robert H Slover, Stacey M Anderson,[...]. Diabetes Technol Ther 2017
221
9


Role of emerging new technologies.
Satish K Garg. Diabetes Technol Ther 2008
4
25

Continuous Glucose Monitoring vs Conventional Therapy for Glycemic Control in Adults With Type 1 Diabetes Treated With Multiple Daily Insulin Injections: The GOLD Randomized Clinical Trial.
Marcus Lind, William Polonsky, Irl B Hirsch, Tim Heise, Jan Bolinder, Sofia Dahlqvist, Erik Schwarz, Arndís Finna Ólafsdóttir, Anders Frid, Hans Wedel,[...]. JAMA 2017
214
9


Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial.
Paresh Dandona, Chantal Mathieu, Moshe Phillip, Lars Hansen, Steven C Griffen, Diethelm Tschöpe, Fredrik Thorén, John Xu, Anna Maria Langkilde. Lancet Diabetes Endocrinol 2017
136
9

Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes.
Steven P Marso, Gilbert H Daniels, Kirstine Brown-Frandsen, Peter Kristensen, Johannes F E Mann, Michael A Nauck, Steven E Nissen, Stuart Pocock, Neil R Poulter, Lasse S Ravn,[...]. N Engl J Med 2016
9

Advances in Care for Insulin-Requiring Patients Without Closed Loop.
Rayhan A Lal, Bruce Buckingham, David M Maahs. Diabetes Technol Ther 2018
3
33

The lifetime cost of diabetes and its implications for diabetes prevention.
Xiaohui Zhuo, Ping Zhang, Lawrence Barker, Ann Albright, Theodore J Thompson, Edward Gregg. Diabetes Care 2014
93
9

Financial costs for families of children with Type 1 diabetes in lower-income countries.
G D Ogle, H Kim, A C Middlehurst, M Silink, A J Jenkins. Diabet Med 2016
23
9

Canagliflozin and Cardiovascular and Renal Events in Type 2 Diabetes.
Bruce Neal, Vlado Perkovic, Kenneth W Mahaffey, Dick de Zeeuw, Greg Fulcher, Ngozi Erondu, Wayne Shaw, Gordon Law, Mehul Desai, David R Matthews. N Engl J Med 2017
9

Diabetes 2030: Insights from Yesterday, Today, and Future Trends.
William R Rowley, Clement Bezold, Yasemin Arikan, Erin Byrne, Shannon Krohe. Popul Health Manag 2017
174
9

Efficacy and Safety of Degludec versus Glargine in Type 2 Diabetes.
Steven P Marso, Darren K McGuire, Bernard Zinman, Neil R Poulter, Scott S Emerson, Thomas R Pieber, Richard E Pratley, Poul-Martin Haahr, Martin Lange, Kirstine Brown-Frandsen,[...]. N Engl J Med 2017
257
9

Current state of type 1 diabetes treatment in the U.S.: updated data from the T1D Exchange clinic registry.
Kellee M Miller, Nicole C Foster, Roy W Beck, Richard M Bergenstal, Stephanie N DuBose, Linda A DiMeglio, David M Maahs, William V Tamborlane. Diabetes Care 2015
689
9

IDF Diabetes Atlas: Global estimates of diabetes prevalence for 2017 and projections for 2045.
N H Cho, J E Shaw, S Karuranga, Y Huang, J D da Rocha Fernandes, A W Ohlrogge, B Malanda. Diabetes Res Clin Pract 2018
9

Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009.
Dana Dabelea, Elizabeth J Mayer-Davis, Sharon Saydah, Giuseppina Imperatore, Barbara Linder, Jasmin Divers, Ronny Bell, Angela Badaru, Jennifer W Talton, Tessa Crume,[...]. JAMA 2014
667
9


Glycaemic control of Type 1 diabetes in clinical practice early in the 21st century: an international comparison.
J A McKnight, S H Wild, M J E Lamb, M N Cooper, T W Jones, E A Davis, S Hofer, M Fritsch, E Schober, J Svensson,[...]. Diabet Med 2015
153
9

Emerging Technologies for Diabetes Care.
Timothy S Bailey, John Walsh, Jenine Y Stone. Diabetes Technol Ther 2018
12
9

Effects of Sotagliflozin Added to Insulin in Patients with Type 1 Diabetes.
Satish K Garg, Robert R Henry, Phillip Banks, John B Buse, Melanie J Davies, Gregory R Fulcher, Paolo Pozzilli, Diane Gesty-Palmer, Pablo Lapuerta, Rafael Simó,[...]. N Engl J Med 2017
172
9

Preserving Skin Integrity with Chronic Device Use in Diabetes.
Laurel H Messer, Cari Berget, Christie Beatson, Sarit Polsky, Gregory P Forlenza. Diabetes Technol Ther 2018
26
9


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.